Physician

Ajay Chawla, MD

According to 2025 Medicare claims, Ajay Chawla, MD (NPI: 1982636700) practices internal medicine in the Mansfield, OH market, with the plurality of this provider's patient population coming from Richland, OH. Chawla uses personal NPI as billing NPI and primary practice location at 44875-1104. Chawla is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and Aledade 157 OH MSSP Enhanced (ACO ID: A5360), participating under the MSSP model.

Chawla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 828 traditional Medicare patients, billed 5,763 HCPCS/CPT codes, and received $333,156 in Medicare payments. The top billing code was 99306 (Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more). Part D data shows 32,544 prescription claims across 1,338 beneficiaries totaling $2,260,694 in drug costs, led by Eliquis (Apixaban). DME data shows 1,316 claims. Open Payments data shows 2 records totaling $232. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,214	8,539	$380,247
2016	1,248	8,223	$336,443
2017	1,259	8,521	$343,392
2018	1,203	10,016	$462,853
2019	1,157	9,191	$432,278
2020	1,066	8,177	$398,672
2021	1,046	6,995	$398,007
2022	929	5,981	$390,171
2023	782	5,040	$339,375
2024	828	5,763	$333,156

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,372	41,101	$2,633,958
2016	1,348	39,691	$2,409,107
2017	1,314	39,859	$2,376,338
2018	1,344	41,086	$2,452,480
2019	1,377	39,946	$2,533,728
2020	1,326	37,745	$2,407,875
2021	1,357	35,763	$2,363,282
2022	1,369	34,791	$2,549,020
2023	1,306	29,360	$2,448,230
2024	1,338	32,544	$2,260,694

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	790	2,613	$162,098
2016	899	2,822	$140,574
2017	935	2,894	$104,580
2018	810	2,713	$108,536
2019	781	2,661	$139,080
2020	705	2,687	$145,031
2021	500	1,929	$109,876
2022	398	1,635	$94,136
2023	425	1,480	$84,881
2024	401	1,316	$74,066

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	145	152	$132
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	482	482	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	383	597	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	536	1,162	$59
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	156	420	$54

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	570	23,463	$447,964
Ozempic	Semaglutide	106	4,648	$151,472
Jardiance	Empagliflozin	140	7,122	$134,431
Trulicity	Dulaglutide	46	2,520	$84,496
Xarelto	Rivaroxaban	77	3,815	$69,685

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	16	65	$28,059
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	49	$6,455
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	14	82	$5,864
A7031	Face mask interface, replacement for full face mask, each	N	25	59	$5,195
E0601	Continuous positive airway pressure (cpap) device	Y	27	157	$4,036

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$232	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ajay Chawla, MD?

Tedicare shows public-source Medicare data for Ajay Chawla, MD (NPI 1982636700), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ajay Chawla, MD have ACO affiliation data?

Ajay Chawla, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and Aledade 157 OH MSSP Enhanced (MSSP, ACO ID A5360).

What billing organization is linked to Ajay Chawla, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Ajay Chawla, MD have Open Payments data?

Ajay Chawla, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.